1. Home
  2. ESTC vs AMRX Comparison

ESTC vs AMRX Comparison

Compare ESTC & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elastic N.V.

ESTC

Elastic N.V.

N/A

Current Price

$85.94

Market Cap

6.5B

Sector

Technology

ML Signal

N/A

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

N/A

Current Price

$17.91

Market Cap

5.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ESTC
AMRX
Founded
2012
2002
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
5.8B
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
ESTC
AMRX
Price
$85.94
$17.91
Analyst Decision
Buy
Strong Buy
Analyst Count
28
5
Target Price
$91.38
$15.60
AVG Volume (30 Days)
2.1M
1.8M
Earning Date
05-28-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
429.81
157.89
EPS
3.43
0.37
Revenue
$1,739,331,000.00
N/A
Revenue This Year
$19.06
$4.48
Revenue Next Year
$13.42
$7.13
P/E Ratio
$25.04
$48.38
Revenue Growth
17.26
N/A
52 Week Low
$42.05
$9.20
52 Week High
$96.07
$19.26

Technical Indicators

Market Signals
Indicator
ESTC
AMRX
Relative Strength Index (RSI) 74.11 52.84
Support Level $69.33 $16.61
Resistance Level $96.07 $18.13
Average True Range (ATR) 3.80 0.67
MACD 0.91 -0.08
Stochastic Oscillator 88.64 54.41

Price Performance

Historical Comparison
ESTC
AMRX

About ESTC Elastic N.V.

Elastic is a software company that specializes in AI-search, observability, and security deployments. Its search division offers both traditional keyword search and vector search methods to enable more context-aware querying. The software has open-source origins but generates revenue through valuable add-ons, including simplified data orchestration and server scaling techniques.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: